An Update On Gene Therapy Approaches For Parkinson'S Disease: Restoration Of Dopaminergic Function
JOURNAL OF PARKINSONS DISEASE(2021)
摘要
At present there is a significant unmet need for clinically available treatments for Parkinson's disease (PD) patients to stably restore balance to dopamine network function, leaving patients with inadequate management of symptoms as the disease progresses. Gene therapy is an attractive approach to impart a durable effect on neuronal function through introduction of genetic material to reestablish dopamine levels and/or functionally recover dopaminergic signaling by improving neuronal health. Ongoing clinical gene therapy trials in PD are focused on enzymatic enhancement of dopamine production and/or the restoration of the nigrostriatal pathway to improve dopaminergic network function. In this review, we discuss data from current gene therapy trials for PD and recent advances in study design and surgical approaches.
更多查看译文
关键词
Gene therapy, Parkinson's disease, aromatic-L-amino-acid decarboxylase, glial cell line-derived neurotrophic factor, image-guided convection-enhanced delivery, clinical trial design
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要